Novozymes诺维信品牌怎么样 申请店铺

我要投票 Novozymes诺维信在饲料添加剂行业中的票数:595 更新时间:2025-08-07
Novozymes诺维信是哪个国家的品牌?「Novozymes诺维信」是诺维信(中国)生物技术有限公司旗下著名品牌。该品牌发源于天津,由创始人Graziela Malucelli在1994-10-05期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力Novozymes诺维信品牌出海!将品牌入驻外推网,定制Novozymes诺维信品牌推广信息,可以显著提高Novozymes诺维信产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

Novozymes诺维信怎么样

诺维信公司是全球工业酶制剂和微生物制剂的主导企业,拥有超过40%的世界市场份额。2001年,诺维信公司从丹麦著名的制药公司诺和诺德公司分离出来;2004年,诺维信公司全球销售收入达到10亿美金,业务遍及130个国家。迄今为止,诺维信已经连续五年名列道琼斯可持续发展指数全球和欧洲医药/生物技术板块企业可持续发展第一名。诺维信拥有4,000多项有效专利、正在申请的专利和专利许可。在研发工作中,诺维信运用了传统微生物学、现代生物化学和分子生物学领域的多项先进核心技术,包括表达克隆、重组技术、蛋白工程和高通量筛选技术等,力争为广大客户提供所需的各种酶类。

诺维信是丹麦在华最大投资企业之一,自1994年起累计投资2亿美元,在天津经济技术开发区建立了全球酶制剂生产基地,在北京中关村科技园区设立了中国首家外资生物技术研发中心。此外,诺维信在江苏太仓建立了苏州宏达制酶有限公司;在沈阳设立了微生物生产基地;销售网络遍及全国。

中国在诺维信全球化战略中占有举足轻重的地位,已逐渐成为诺维信最重要的业务增长引擎和研发、生产及运营中心。为了更接近蓬勃发展的中国市场,以更灵活高效的方式满足中国客户的多样化需求,诺维信正在将越来越多的功能和业务重心转移到中国,并在本地广纳贤士。

在中国,诺维信秉承经营业绩、环境表现和社会责任并举的“三重底线”,积极研发适合本地市场的新产品和新应用,解决中国工业和工艺所面临的问题;同时投身地方环保事业,支持大学环境与生命科学研究及教育,倡导和推动生态工业与循环经济,立志成为中国最佳生物解决方案提供商和可持续发展的战略伙伴。

Novozyme is the leading enterprise of industrial enzyme preparation and microbial preparation in the world, with more than 40% of the world market share. In 2001, Novozymes was separated from Novo Nordisk, a famous pharmaceutical company in Denmark. In 2004, Novozymes's global sales revenue reached US $1 billion, with businesses in 130 countries. So far, Novozymes has ranked first in the world of Dow Jones sustainable development index and in the sustainable development of European pharmaceutical / biotechnology companies for five consecutive years. Novozymes has more than 4000 valid patents, patent applications and patent licenses. In the R & D work, novozyme has applied a number of advanced core technologies in the fields of traditional microbiology, modern biochemistry and molecular biology, including expression cloning, recombination technology, protein engineering and high-throughput screening technology, striving to provide customers with all kinds of enzymes they need. Novozymes is one of the largest Danish investment enterprises in China. Since 1994, Novozymes has invested 200 million US dollars in total. It has established a global enzyme production base in Tianjin Economic and Technological Development Zone and the first foreign-funded biotechnology research and development center in China in Zhongguancun Science and Technology Park, Beijing. In addition, novozyme has established Suzhou Hongda enzyme Manufacturing Co., Ltd. in Taicang, Jiangsu Province; established a microbial production base in Shenyang; and has a sales network throughout the country. China plays an important role in novozyme's global strategy and has gradually become the most important business growth engine and R & D, production and operation center of novozyme. In order to get closer to the booming Chinese market and meet the diversified needs of Chinese customers in a more flexible and efficient way, novozyme is transferring more and more functions and business focus to China and attracting talents locally. In China, Novozymes adheres to the "triple bottom line" of business performance, environmental performance and social responsibility, actively develops new products and applications suitable for the local market, and solves the problems faced by Chinese industry and technology; at the same time, Novozymes devotes itself to the local environmental protection, supports the research and education of university environment and life science, advocates and promotes the ecological industry and circular economy, and aspires to become China China's best biological solution provider and strategic partner for sustainable development.

本文链接: https://brand.waitui.com/6af0c06dc.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

美国白宫国家经济委员会主任哈塞特:可能会听到苹果公司新建工厂的消息

8月6日,据报道,美国白宫国家经济委员会主任哈塞特表示,可能会听到苹果公司新建工厂的消息。另外,在被问及美联储职位相关问题时,哈塞特表示乐于探讨这一挑战。(界面)

2小时前

美股大型科技股盘前涨跌不一,苹果涨超1%

36氪获悉,美股大型科技股盘前涨跌不一,苹果涨超1%,亚马逊、微软涨0.52%,Meta涨0.44%,Arm涨0.14%,谷歌涨0.06%;英伟达跌近1%,特斯拉跌0.21%。

2小时前

热门中概股美股盘前多数上涨,爱奇艺涨超6%

36氪获悉,热门中概股美股盘前多数上涨,截至发稿,爱奇艺涨超6%,小鹏汽车涨超2%,蔚来涨2%,B站、阿里巴巴、拼多多、百度涨超1%;理想汽车跌超3%。

2小时前

汇川技术:正在积极开发人形机器人相关的零部件产品

36氪获悉,汇川技术在互动平台表示,公司正在积极开发人形机器人相关的零部件产品,包括电机、驱动、执行器模组,上肢臂等,今年的进展主要是从预研转向产品化,过程中积极与整机公司和集成商进行沟通合作。

2小时前

拟通过香港IPO融资3亿美元?爱奇艺:暂时无法提供更多信息

针对爱奇艺寻求通过在香港市场上市融资3亿美元的消息,爱奇艺方面回应称:暂时没有更多信息可以提供。(财联社)

2小时前

本页详细列出关于Novozymes诺维信的品牌信息,含品牌所属公司介绍,Novozymes诺维信所处行业的品牌地位及优势。
咨询